Histiocytoses of the L group
| Disease . | Subtypes . |
|---|---|
| LCH | LCH SS |
| LCH lung+ | |
| LCH MS-RO+ | |
| LCH MS-RO− | |
| Associated with another myeloproliferative/myelodysplastic disorder | |
| ICH | |
| ECD | ECD classical type |
| ECD without bone involvement | |
| Associated with another myeloproliferative/myelodysplastic disorder | |
| Extracutaneous or disseminated JXG with MAPK-activating mutation or ALK translocations | |
| Mixed ECD and LCH | |
| Disease . | Subtypes . |
|---|---|
| LCH | LCH SS |
| LCH lung+ | |
| LCH MS-RO+ | |
| LCH MS-RO− | |
| Associated with another myeloproliferative/myelodysplastic disorder | |
| ICH | |
| ECD | ECD classical type |
| ECD without bone involvement | |
| Associated with another myeloproliferative/myelodysplastic disorder | |
| Extracutaneous or disseminated JXG with MAPK-activating mutation or ALK translocations | |
| Mixed ECD and LCH | |
ECD, Erdheim-Chester disease; ICH, indeterminate cell histiocytosis; LCH, Langerhans cell histiocytosis; MS, multiple system; RO, risk organ; SS, single system.